The Journal of clinical investigation

publication venue for

RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. 2022
SARS-CoV-2 infection of the placenta. 2020
Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus. 1985
Pharmacological suppression of the OTUD4-CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers. 2024
Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage. 2024
KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.. 134. 2024
The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma. 2024
A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels. 2024
Breast cancer immunopeptidomes contain numerous shared tumor antigens.. 134. 2024
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models. 2023
Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. 2023
Impaired T cell IRE1α-XBP1 signaling directs inflammation in experimental Heart Failure with Preserved Ejection Fraction. 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies. 2023
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.. 133. 2023
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth.. 133. 2023
Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis. 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.. 133. 2023
IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models.. 133. 2023
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct Omicron subvariants. 2023
Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege. 2023
Long noncoding RNA LEENE promotes angiogenesis and ischemic recovery in diabetes models.. 133. 2023
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.. 132. 2022
Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor.. 132. 2022
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade.. 132. 2022
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.. 132. 2022
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.. 132. 2022
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection. 2022
Tumor associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B-cell lymphoma. 2022
Ataxia-linked SLC1A3 mutations alter EAAT1 chloride channel activity and glial regulation of CNS function.. 132. 2022
IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity.. 132. 2022
Protein kinase A drives paracrine crisis and WNT4-dependent testis tumor in Carney complex.. 131. 2021
SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.. 131. 2021
T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice.. 131. 2021
Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF.. 131. 2021
FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.. 131. 2021
Innovations in MD-only physician-scientist training: experiences from the Burroughs Wellcome Fund physician-scientist institutional award initiative.. 131. 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.. 131. 2021
Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.. 131. 2021
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.. 131. 2021
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.. 131. 2021
Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.. 131. 2021
Generating evidence for therapeutic effects: the need for well-conducted randomized trials.. 131. 2021
Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.. 131. 2021
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. 131. 2021
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.. 130. 2020
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.. 130. 2020
ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.. 130. 2020
Cyclophilin D-dependent oligodendrocyte mitochondrial ion leak contributes to neonatal white matter injury.. 130. 2020
Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City.. 130. 2020
Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis.. 130. 2020
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.. 130. 2020
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.. 130. 2020
Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood.. 130. 2020
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.. 130. 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.. 130. 2020
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.. 130. 2020
Decreased sphingolipid synthesis in children with 17q21 asthma-risk genotypes.. 130. 2020
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia.. 130. 2020
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.. 130. 2020
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.. 130. 2020
Using admission statistics to encourage diverse applicants to MD-PhD programs.. 130. 2020
Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.. 129. 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.. 129. 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.. 129. 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.. 129. 2019
Systemic silencing of PHD2 causes reversible immune regulatory dysfunction.. 129. 2019
Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice.. 129. 2019
Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage.. 129. 2019
Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2.. 129. 2019
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.. 129. 2019
Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.. 129. 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.. 129. 2019
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.. 129. 2019
Gene fitness landscape of group A streptococcus during necrotizing myositis.. 129. 2019
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.. 129. 2019
Cardiac CaV1.2 channels require β subunits for β-adrenergic-mediated modulation but not trafficking.. 129. 2019
Peptide-based PET quantifies target engagement of PD-L1 therapeutics.. 129. 2019
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup.. 129. 2018
CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.. 129. 2018
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.. 129. 2018
Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.. 128. 2018
E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.. 128. 2018
The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction.. 128. 2018
Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.. 128. 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.. 128. 2018
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.. 128. 2018
SNAP23 regulates BAX-dependent adipocyte programmed cell death independently of canonical macroautophagy.. 128. 2018
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.. 128. 2018
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.. 128. 2018
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.. 128. 2018
COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.. 128. 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.. 128. 2018
iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.. 128. 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.. 128. 2018
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.. 128. 2018
Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.. 128. 2017
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.. 128. 2017
Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress.. 128. 2017
Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution after myelosuppression.. 127. 2017
Endothelial transplantation rejuvenates aged hematopoietic stem cell function.. 127. 2017
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.. 127. 2017
Introduction of Laurie H. Glimcher, MD.. 127. 2017
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clones.. 127. 2017
Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus.. 127. 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.. 127. 2017
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.. 127. 2017
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα.. 127. 2017
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.. 127. 2017
Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells.. 127. 2017
TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.. 127. 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.. 127. 2017
Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.. 127. 2017
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.. 127. 2017
Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.. 127. 2017
Prolonged red cell storage before transfusion increases extravascular hemolysis.. 127. 2016
Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.. 126. 2016
Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.. 126. 2016
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.. 126. 2016
Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control.. 126. 2016
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia.. 126. 2016
Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.. 126. 2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.. 126. 2016
Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.. 126. 2016
Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.. 126. 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.. 126. 2016
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.. 126. 2016
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.. 126. 2016
c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.. 126. 2016
Schwann cells induce cancer cell dispersion and invasion.. 126. 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.. 126. 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.. 126. 2016
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.. 126. 2016
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.. 126. 2015
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.. 125. 2015
Insulin demand regulates β cell number via the unfolded protein response.. 125. 2015
A molecular trigger for intercontinental epidemics of group A Streptococcus.. 125. 2015
Aaron J. Marcus: in pursuit of perfection.. 125. 2015
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.. 125. 2015
Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.. 125. 2015
Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage.. 125. 2015
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.. 125. 2015
Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells.. 125. 2015
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.. 125. 2015
Resetting the transcription factor network reverses terminal chronic hepatic failure.. 125. 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.. 125. 2015
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.. 125. 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma.. 125. 2015
Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.. 125. 2015
Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.. 125. 2015
Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.. 125. 2015
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis.. 125. 2015
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.. 125. 2014
mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity.. 125. 2014
RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.. 124. 2014
Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD.. 124. 2014
Network modulation following sham surgery in Parkinson's disease.. 124. 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.. 124. 2014
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.. 124. 2014
Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.. 124. 2014
Melanoma NOS1 expression promotes dysfunctional IFN signaling.. 124. 2014
Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation.. 124. 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response.. 124. 2014
Long-lived intestinal tuft cells serve as colon cancer-initiating cells.. 124. 2014
Taxonomy of breast cancer based on normal cell phenotype predicts outcome.. 124. 2014
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.. 124. 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.. 124. 2014
Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.. 124. 2013
Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.. 124. 2013
Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.. 123. 2013
CX3CR1-dependent renal macrophage survival promotes Candida control and host survival.. 123. 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.. 123. 2013
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.. 123. 2013
Retinal angiogenesis suppression through small molecule activation of p53.. 123. 2013
Metabolic network as a progression biomarker of premanifest Huntington's disease.. 123. 2013
Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.. 123. 2013
HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.. 123. 2013
Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.. 123. 2013
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.. 123. 2013
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.. 123. 2013
GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.. 123. 2013
Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice.. 123. 2013
Calcium influx through L-type CaV1.2 Ca2+ channels regulates mandibular development.. 123. 2013
GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement.. 123. 2013
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.. 123. 2013
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.. 123. 2013
β4 Integrin signaling induces expansion of prostate tumor progenitors.. 123. 2013
p62 links β-adrenergic input to mitochondrial function and thermogenesis.. 123. 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.. 123. 2012
C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.. 122. 2012
Extrathymic development of murine T cells after bone marrow transplantation.. 122. 2012
HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.. 122. 2012
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.. 122. 2012
A misplaced lncRNA causes brachydactyly in humans.. 122. 2012
ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension.. 122. 2012
Th9 cells promote antitumor immune responses in vivo.. 122. 2012
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.. 122. 2012
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.. 122. 2012
Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.. 122. 2012
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.. 122. 2012
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.. 122. 2012
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.. 122. 2012
Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice.. 122. 2012
Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.. 122. 2011
In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.. 121. 2011
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.. 121. 2011
Activation of K(ATP) channels suppresses glucose production in humans.. 121. 2011
MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice.. 121. 2011
SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.. 121. 2011
TCR-dependent transformation of mature memory phenotype T cells in mice.. 121. 2011
In vitro differentiation of human macrophages with enhanced antimycobacterial activity.. 121. 2011
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis.. 121. 2011
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.. 121. 2011
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.. 121. 2011
Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.. 121. 2011
Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.. 121. 2011
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.. 121. 2011
Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.. 121. 2011
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.. 121. 2011
Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice.. 121. 2011
Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.. 121. 2010
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.. 120. 2010
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.. 120. 2010
Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.. 120. 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.. 120. 2010
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration.. 120. 2010
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice.. 120. 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans.. 120. 2010
Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.. 120. 2010
Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice.. 120. 2010
Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice.. 120. 2010
CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.. 120. 2010
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.. 120. 2010
Identification of a B cell signature associated with renal transplant tolerance in humans.. 120. 2010
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.. 120. 2010
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.. 120. 2010
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.. 120. 2010
FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice.. 120. 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.. 120. 2009
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.. 119. 2009
Tregs control the development of symptomatic West Nile virus infection in humans and mice.. 119. 2009
Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.. 119. 2009
Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines.. 119. 2009
Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.. 119. 2009
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.. 119. 2009
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.. 119. 2009
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.. 119. 2009
The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.. 119. 2009
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.. 119. 2009
Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras.. 119. 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.. 118. 2008
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.. 117. 2007
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.. 117. 2007
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.. 117. 2007
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.. 117. 2007
Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.. 117. 2007
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.. 117. 2007
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.. 117. 2007
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.. 117. 2007
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.. 117. 2007
Improved prediction of prostate cancer recurrence through systems pathology.. 117. 2007
Mature B cells class switched to IgD are autoreactive in healthy individuals.. 117. 2007
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.. 117. 2007
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.. 116. 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.. 116. 2006
NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway.. 116. 2006
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.. 116. 2006
Possible axonal regrowth in late recovery from the minimally conscious state.. 116. 2006
Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.. 116. 2006
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity.. 116. 2006
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.. 116. 2006
Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity.. 116. 2006
Differential exoprotease activities confer tumor-specific serum peptidome patterns.. 116. 2006
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.. 116. 2005
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.. 115. 2005
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.. 115. 2005
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.. 115. 2005
Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.. 115. 2005
Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors.. 115. 2005
The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.. 115. 2005
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.. 115. 2005
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.. 115. 2005
SDF-1 is both necessary and sufficient to promote proliferative retinopathy.. 115. 2005
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.. 114. 2004
Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference.. 114. 2004
Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes.. 114. 2004
PKCbeta regulates ischemia/reperfusion injury in the lung.. 113. 2004
Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.. 113. 2004
Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.. 113. 2004
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.. 113. 2004
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.. 113. 2004
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.. 112. 2003
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.. 112. 2003
Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance.. 112. 2003
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.. 112. 2003
Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis.. 111. 2003
Central role of RAGE-dependent neointimal expansion in arterial restenosis.. 111. 2003
The emerging science of body weight regulation and its impact on obesity treatment.. 111. 2003
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.. 110. 2002
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.. 110. 2002
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.. 110. 2002
Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.. 110. 2002
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.. 109. 2002
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.. 109. 2002
Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.. 109. 2002
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.. 109. 2002
Multiple immuno-regulatory defects in type-1 diabetes.. 109. 2002
The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT.. 108. 2001
Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.. 108. 2001
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.. 107. 2001
Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.. 107. 2001
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.. 107. 2001
Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling.. 107. 2001
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.. 106. 2000
Role of the Cdc25A phosphatase in human breast cancer.. 106. 2000
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.. 106. 2000
Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.. 106. 2000
Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.. 105. 2000
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.. 105. 2000
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.. 105. 2000
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.. 105. 2000
Wnt-1 regulation of connexin43 in cardiac myocytes.. 105. 2000
A transgenic rabbit model for human hypertrophic cardiomyopathy.. 104. 1999
Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.. 104. 1999
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.. 104. 1999
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.. 104. 1999
Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog.. 104. 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.. 104. 1999
Augmentation of pulmonary host defense against Pseudomonas by FcgammaRIIA cDNA transfer to the respiratory epithelium.. 104. 1999
Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.. 104. 1999
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.. 104. 1999
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.. 103. 1999
Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.. 103. 1999
Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury.. 103. 1999
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.. 103. 1999
CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.. 103. 1999
Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice.. 103. 1999
Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.. 102. 1998
Tumor immunity and autoimmunity induced by immunization with homologous DNA.. 102. 1998
In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.. 101. 1998
Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.. 101. 1998
Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.. 101. 1998
Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).. 101. 1998
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.. 100. 1997
Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.. 100. 1997
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.. 100. 1997
Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.. 100. 1997
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.. 100. 1997
Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells.. 100. 1997
Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.. 100. 1997
Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.. 99. 1997
Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.. 99. 1997
Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.. 99. 1997
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.. 99. 1997
Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.. 99. 1997
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.. 99. 1997
Bacterial infection induces nitric oxide synthase in human neutrophils.. 99. 1997
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.. 98. 1996
Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44.. 98. 1996
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.. 98. 1996
1H-NMR detectable fatty acyl chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity.. 98. 1996
Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet.. 97. 1996
A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene.. 97. 1996
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.. 97. 1996
Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia.. 97. 1996
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.. 97. 1996
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.. 97. 1996
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.. 97. 1996
Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.. 96. 1995
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.. 96. 1995
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.. 96. 1995
Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.. 96. 1995
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.. 96. 1995
Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals.. 96. 1995
Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.. 96. 1995
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.. 96. 1995
T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.. 96. 1995
Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo.. 95. 1995
Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner.. 95. 1995
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.. 95. 1995
Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.. 95. 1995
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.. 95. 1995
In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.. 95. 1995
Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries.. 95. 1995
Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.. 94. 1994
Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans.. 94. 1994
Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade.. 94. 1994
Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones.. 94. 1994
A novel mobile element inserted in the alpha spectrin gene: spectrin dayton. A truncated alpha spectrin associated with hereditary elliptocytosis.. 94. 1994
Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus.. 94. 1994
Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.. 94. 1994
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.. 93. 1994
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.. 93. 1994
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.. 93. 1994
Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress.. 93. 1994
Vasodilation of rat retinal microvessels induced by monobutyrin. Dysregulation in diabetes.. 92. 1993
Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.. 92. 1993
Human keratinocytes are a major source of cutaneous platelet-derived growth factor.. 92. 1993
Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.. 91. 1993
Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.. 91. 1993
Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.. 91. 1993
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.. 91. 1993
Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype.. 90. 1992
Novel Fc gamma receptor I family gene products in human mononuclear cells.. 90. 1992
Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity.. 90. 1992
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.. 90. 1992
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.. 90. 1992
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.. 90. 1992
Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation.. 90. 1992
Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.. 90. 1992
Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).. 90. 1992
Molecular genetics of steroid 5 alpha-reductase 2 deficiency.. 90. 1992
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.. 90. 1992
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.. 89. 1992
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.. 89. 1992
Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.. 89. 1992
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.. 89. 1992
Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation.. 88. 1991
Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.. 88. 1991
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.. 88. 1991
Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells.. 88. 1991
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.. 88. 1991
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.. 88. 1991
150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.. 88. 1991
Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.. 88. 1991
Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung.. 88. 1991
Expression of the secretory leukoprotease inhibitor gene in epithelial cells.. 87. 1991
L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits.. 87. 1991
Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.. 87. 1991
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.. 87. 1991
Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.. 87. 1991
Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.. 86. 1990
Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.. 86. 1990
The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes.. 86. 1990
Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract.. 86. 1990
Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.. 86. 1990
Clonal composition of benign and malignant human thyroid tumors.. 86. 1990
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.. 86. 1990
Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii.. 85. 1990
Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis.. 85. 1990
Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.. 85. 1990
Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.. 85. 1990
Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.. 85. 1990
Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.. 85. 1990
In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease.. 85. 1990
Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver.. 85. 1990
Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.. 85. 1990
Role of complement in mouse macrophage binding of Haemophilus influenzae type b.. 85. 1990
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells.. 84. 1989
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.. 84. 1989
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.. 84. 1989
Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.. 84. 1989
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.. 83. 1989
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.. 83. 1989
Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.. 83. 1989
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.. 83. 1989
Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.. 83. 1989
Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism.. 82. 1988
Binding of Lys-plasminogen to monocytes/macrophages.. 82. 1988
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.. 82. 1988
Alveolar macrophages release an insulin-like growth factor I-type molecule.. 82. 1988
Amplification of altered self-reactive cytolytic T lymphocyte responses by cloned, allospecific human Th cells.. 82. 1988
Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.. 82. 1988
Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis.. 82. 1988
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.. 82. 1988
Tumor necrosis factor and the acute metabolic response to tissue injury in man.. 82. 1988
Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.. 82. 1988
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy.. 81. 1988
Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells.. 81. 1988
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.. 81. 1988
In vitro adenylate cyclase-stimulating activity predicts the occurrence of humoral hypercalcemia of malignancy in nude mice.. 81. 1988
Binding of tissue plasminogen activator to cultured human endothelial cells.. 80. 1987
Modulation of fibronectin gene expression in human mononuclear phagocytes.. 80. 1987
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.. 80. 1987
PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.. 80. 1987
Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis.. 80. 1987
Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.. 80. 1987
Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy.. 80. 1987
Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.. 80. 1987
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.. 80. 1987
Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation.. 80. 1987
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.. 80. 1987
Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3.. 80. 1987
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.. 79. 1987
Gamma-interferon inhibits collagen synthesis in vivo in the mouse.. 79. 1987
Isolation of the thrombospondin membrane receptor.. 79. 1987
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion.. 79. 1987
Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.. 78. 1986
Preferential light absorption in atheromas in vitro. Implications for laser angioplasty.. 78. 1986
Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages.. 78. 1986
Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals.. 77. 1986
Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.. 77. 1986
In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.. 77. 1986
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.. 77. 1986
Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.. 77. 1986
Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes.. 77. 1986
In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat.. 77. 1986
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.. 76. 1985
Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.. 76. 1985
Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability.. 76. 1985
Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.. 76. 1985
Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.. 76. 1985
Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus.. 76. 1985
Hydrogen peroxide from cellular metabolism of cystine. A requirement for lysis of murine tumor cells by vernolepin, a glutathione-depleting antineoplastic.. 76. 1985
Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.. 76. 1985
Resistance of human tumor cells in vitro to oxidative cytolysis.. 76. 1985
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.. 75. 1985
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.. 75. 1985
Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.. 75. 1985
Plasmin inhibition of platelet function and of arachidonic acid metabolism.. 75. 1985
Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.. 75. 1985
Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.. 75. 1985
Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.. 75. 1985
Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.. 74. 1984
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.. 74. 1984
Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro.. 74. 1984
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.. 74. 1984
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.. 74. 1984
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.. 74. 1984
Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.. 74. 1984
Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells.. 74. 1984
Natural killer cells are present in the normal human lung but are functionally impotent.. 74. 1984
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung.. 74. 1984
Porphyrin-heme biosynthesis in organotypic cultures of mouse dorsal root ganglia. Effects of heme and lead on porphyrin synthesis and peripheral myelin.. 74. 1984
An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin.. 74. 1984
Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.. 74. 1984
Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.. 73. 1984
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.. 73. 1984
Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.. 73. 1984
Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit.. 73. 1984
Complex formation of platelet thrombospondin with histidine-rich glycoprotein.. 73. 1984
Interferon enhances prostacyclin production by cultured vascular endothelial cells.. 73. 1984
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.. 72. 1983
Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.. 72. 1983
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.. 72. 1983
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.. 72. 1983
Metabolism of estradiol in liver cell culture. Differential responses of C-2 and C-16 oxidations to drugs and other chemicals that induce selective species of cytochrome P-450.. 72. 1983
Genetic regulation of a structural polymorphism of human C3b receptor.. 72. 1983
Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.. 72. 1983
Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.. 71. 1983
Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis.. 71. 1983
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.. 71. 1983
Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics.. 71. 1983
Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.. 70. 1982
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.. 70. 1982
Complex formation of platelet thrombospondin with fibrinogen.. 70. 1982
Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.. 70. 1982
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.. 70. 1982
Sperm-related antigens, antibodies, and circulating immune complexes in sera of recently vasectomized men.. 70. 1982
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.. 69. 1982
Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.. 69. 1982
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.. 69. 1982
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.. 69. 1982
Leucine meal increases glutamine and total nitrogen release from forearm muscle.. 68. 1981
Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.. 68. 1981
Oxidant injury of lung parenchymal cells.. 68. 1981
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.. 68. 1981
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.. 68. 1981
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.. 68. 1981
Regulation of collagen production by the beta-adrenergic system.. 67. 1981
Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.. 67. 1981
Platelet Fc receptor. Increased expression in myeloproliferative disease.. 67. 1981
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells.. 67. 1981
Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids.. 67. 1981
Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.. 67. 1981
Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.. 67. 1981
Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.. 66. 1980
Spectrum of immunodeficiencies with Hodgkin's disease.. 66. 1980
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.. 66. 1980
Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.. 66. 1980
Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.. 66. 1980
Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.. 64. 1979
Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion.. 64. 1979
Association of HLA-DRw2 with autoimmune thrombocytopenic purpura.. 63. 1979
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.. 63. 1979
Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.. 63. 1979
The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus.. 63. 1979
Human skin aryl hydrocarbon hydroxylase. Induction by coal tar.. 62. 1978
Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.. 62. 1978
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I.. 61. 1978
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.. 61. 1978
Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.. 61. 1978
Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.. 61. 1978
Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.. 60. 1977
Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations.. 60. 1977
Effects of acetazolamide on proximal tubule C1, Na, and HCO3 transport in normal and acidotic dogs during distal blockade.. 60. 1977
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.. 59. 1977
Immunoinhibition of ristocetin-induced platelet aggregation.. 59. 1977
Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.. 59. 1977
Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes.. 58. 1976
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.. 58. 1976
Lung collagen heterogeneity. Synthesis of type I and type III collagen by rabbit and human lung cells in culture.. 57. 1976
Content and synthesis of glycosaminoglycans in the developing lung.. 56. 1975
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.. 56. 1975
Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.. 56. 1975
Collagen in the human lung. Quantitation of rates of synthesis and partial characterization of composition.. 55. 1975
Stimulators and inhibitors of hepatic porphyrin formation in human sera.. 53. 1974
Impaired lymphocyte function in aged humans.. 53. 1974
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.. 52. 1973
Synthesis of antihemophilic factor antigen by cultured human endothelial cells.. 52. 1973
In vitro antibody-enzyme conjugates with specific bactericidal activity.. 52. 1973
Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines.. 51. 1972
Coproporphyrin I and 3 excretion in bile and urine.. 51. 1972
Effect of insulin on muscle glutamate uptake. Whole blood versus plasma glutamate analysis.. 51. 1972
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein.. 51. 1972
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.. 51. 1972
Characterization of human platelet vascular permeability-enhancing activity.. 51. 1972
Diphenylhydantoin and potassium transport in isolated nerve terminals.. 50. 1971
Estimation of Vmax in auxotonic systoles from the rate of relative increase of isovolumic pressure: (dP-dt)kP.. 50. 1971
Tension prolongation during recovery from myocardial hypoxia.. 50. 1971
Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.. 49. 1970
Increased vascular permeability produced by human platelet granule cationic extract.. 49. 1970
Studies on human platelet protease activity.. 47. 1969
Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase.. 47. 1968
Reduced nicotinamide adenine dinucleotide and the reduction of oxidized glutathione in human erythrocytes.. 47. 1968
The effects of estradiol and estriol on plasma levels of cortisol and thyroid hormone-binding globulins and on aldosterone and cortisol secretion rates in man.. 46. 1967
Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.. 46. 1967
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis.. 133. 2023
The imperative to invest in science has never been greater.. 124. 2014
Secretory products of macrophages: twenty-five years on.. 122. 2012
Endothelium: from cellophane to orchestral maestro.. 122. 2012
Dietary nitrate, nitric oxide, and restenosis.. 121. 2011
Finding a needle in a haystack: whole genome sequencing and mutation discovery in murine models.. 121. 2011
Upper urinary tract pacemaker cells join the GLI club.. 121. 2011
New horizons for studying human hepatotropic infections.. 120. 2010
Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas.. 120. 2010
Predicting response to hepatitis C therapy.. 119. 2009
Fc receptors in immune thrombocytopenias: a target for immunomodulation?. 118. 2008
Something lost--something gained: the ASCI begins its second century.. 118. 2008
Azathioprine: old drug, new actions.. 111. 2003
Can SOCS make arthritis better?. 111. 2003
Renal interstitial fibrosis: remembrance of things past?. 110. 2002
Homocysteine: a sulph'rous fire.. 107. 2001
Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring.. 105. 2000
Circulating endothelial precursors: mystery, reality, and promise.. 105. 2000
Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.. 104. 1999
Bone marrow: an extra-pancreatic hideout for the elusive pancreatic stem cell? 2003
Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential Address. 2008
The future of the ASCI (American Society for Clinical Investigation) : a lesson from 2000 presidential election. 2001
Vascular endothelium: in defense of blood fluidity.. 99. 1997
Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.. 97. 1996
Nitric oxide and biopterin: a study in Chiaroscuro.. 93. 1994
Preventing antiphospholipid antibody-induced fetal loss: a new idea.. 91. 1993
Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. 2021
Immune responses to stroke: mechanisms, modulation, and therapeutic potential. 2020
The balance of power: innate lymphoid cells in tissue inflammation and repair. 2019
Mitochondria in lung disease. 2016
HIV-specific CD8⁺ T cells and HIV eradication. 2016
CAR therapy: the CD19 paradigm. 2015
Mechanisms of vancomycin resistance in Staphylococcus aureus. 2014
Isocitrate dehydrogenase mutations in leukemia. 2013
Brain networks in Huntington disease. 2011
Following the cytokine signaling pathway to leukemogenesis: a chronology. 2008
The legacy of the Philadelphia chromosome. 2007
Molecular-genetic imaging: current and future perspectives. 2003
Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. 2003
Neuronal degeneration and mitochondrial dysfunction. 2003
Intracellular cholesterol transport. 2002
The therapeutic potential of modulating the ceramide/sphingomyelin pathway. 2002
JAK-STAT signaling in asthma. 2002
Stat proteins and oncogenesis. 2002
Recent developments in lymphocyte activation: linking kinases to downstream signaling events. 1999
Inducible nitric oxide synthase: what difference does it make? 1997
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. 1990
Secretory products of macrophages. 1987
Control of heme metabolism with synthetic metalloporphyrins. 1986
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. 2022
Control of inflammation by integration of environmental cues by regulatory T cells. 2013
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. 2001

VIVO Weill Cornell Medical College

The Journal of clinical investigation Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)